Opioid Withdrawal
📧 Sign up to get email alerts when something new happens for Opioid Withdrawal.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-11-05Clinical Trial Update: Comparison of Three Opioid Detoxification Treatment Regimens [Phase 3]
A Phase 3 clinical trial comparing three opioid detoxification regimens has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Oxytocin Treatment of Opioid Dependence [Phase 1, Phase 2]
Phase 1/2 clinical trial update on oxytocin treatment for opioid dependence and withdrawal.
-
CLINICAL_TRIALS research · 2019-01-07Clinical Trial Update: 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence [NA]
A completed clinical trial investigating 5HT3 antagonists for treating opioid withdrawal and preventing progression of physical dependence.
-
FDA approval · 2018-05-16FDA Approved: LUCEMYRA — Original Application (USWM, LLC)
FDA approved LUCEMYRA (lofexidine hydrochloride) as an original NDA for reducing opioid withdrawal symptoms during detoxification.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Buprenorphine in the Emergency Department [Phase 4]
A Phase 4 clinical trial evaluating buprenorphine in the emergency department for opioid withdrawal and opioid-use disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Tramadol to Reduce Opioid Withdrawal Symptoms [Phase 2]
Phase 2 clinical trial evaluating tramadol for reducing opioid withdrawal symptoms in people with opioid use disorder; the study has complet…
-
CLINICAL_TRIALS research · 2016-08-10Clinical Trial Update: A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects [Phase 3]
A Phase 3 clinical trial update evaluating withdrawal effects after dosing oxycodone/naltrexone in individuals maintained on methadone.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Dynorphin 1-13 on Heroin Addiction - 1 [Phase 2]
Phase 2 clinical trial update assessing dynorphin 1-13 for heroin addiction; the study conducted at the University of Minnesota has complete…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated the efficacy of extended-release tramadol for treating prescription opioid withdrawal; results have bee…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals [Phase 2]
A Phase 2 randomized trial compared gabapentin to placebo to facilitate buprenorphine detoxification in opioid-dependent individuals; result…
-
FDA approval · 2013-01-11FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC, adding to the existing approved…